NYSE - Delayed Quote • USD
Nevro Corp. (NVRO)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 5:40 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | ||||
|---|---|---|---|---|
| EPS Est. | -- | -- | -- | -- |
| EPS Actual | -- | -- | -- | -- |
| Difference | -- | -- | -- | -- |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | -0.06 | 0.08 |
| 30 Days Ago | 0 | 0 | -0.06 | 0.08 |
| 60 Days Ago | 0 | 0 | -0.06 | 0.08 |
| 90 Days Ago | 0 | 0 | -0.06 | 0.08 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | NVRO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 1.50% |
| Next Qtr. | -- | -- | -- | 11.40% |
| Current Year | -- | -- | -- | 5.20% |
| Next Year | -- | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | RBC Capital: Sector Perform to Sector Perform | 4/15/2024 |
| Maintains | Mizuho: Neutral to Neutral | 4/11/2024 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 4/8/2024 |
| Maintains | Citigroup: Neutral to Neutral | 4/3/2024 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 2/22/2024 |
| Maintains | Baird: Neutral to Neutral | 2/22/2024 |
Related Tickers
LUNG Pulmonx Corporation
7.52
+0.27%
KIDS OrthoPediatrics Corp.
31.20
+1.86%
SGHT Sight Sciences, Inc.
5.62
-0.35%
CNMD CONMED Corporation
70.01
-1.82%
SILK Silk Road Medical, Inc
17.57
-0.57%
AVNS Avanos Medical, Inc.
18.71
-0.27%
FNA Paragon 28, Inc.
9.64
-4.08%
PRCT PROCEPT BioRobotics Corporation
52.48
-2.36%
LIVN LivaNova PLC
55.94
+1.67%
PEN Penumbra, Inc.
206.15
+0.22%